JPH11322745A5 - - Google Patents

Info

Publication number
JPH11322745A5
JPH11322745A5 JP1999109656A JP10965699A JPH11322745A5 JP H11322745 A5 JPH11322745 A5 JP H11322745A5 JP 1999109656 A JP1999109656 A JP 1999109656A JP 10965699 A JP10965699 A JP 10965699A JP H11322745 A5 JPH11322745 A5 JP H11322745A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
group
nitrogen
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999109656A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11322745A (ja
JP4435325B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH11322745A publication Critical patent/JPH11322745A/ja
Publication of JPH11322745A5 publication Critical patent/JPH11322745A5/ja
Application granted granted Critical
Publication of JP4435325B2 publication Critical patent/JP4435325B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP10965699A 1998-04-17 1999-04-16 置換三環式化合物およびそれを含有する組成物 Expired - Fee Related JP4435325B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6216598A 1998-04-17 1998-04-17
US09/062165 1998-04-17

Publications (3)

Publication Number Publication Date
JPH11322745A JPH11322745A (ja) 1999-11-24
JPH11322745A5 true JPH11322745A5 (enExample) 2007-04-05
JP4435325B2 JP4435325B2 (ja) 2010-03-17

Family

ID=22040624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10965699A Expired - Fee Related JP4435325B2 (ja) 1998-04-17 1999-04-16 置換三環式化合物およびそれを含有する組成物

Country Status (27)

Country Link
EP (2) EP1156050B1 (enExample)
JP (1) JP4435325B2 (enExample)
KR (1) KR19990083234A (enExample)
CN (1) CN1235968A (enExample)
AR (1) AR018185A1 (enExample)
AT (2) ATE254128T1 (enExample)
AU (1) AU757454B2 (enExample)
BR (1) BR9901275A (enExample)
CA (1) CA2269256A1 (enExample)
CO (1) CO5080728A1 (enExample)
CZ (1) CZ137199A3 (enExample)
DE (2) DE69912670T2 (enExample)
EA (1) EA003129B1 (enExample)
ES (2) ES2210979T3 (enExample)
HU (1) HUP9901219A1 (enExample)
ID (1) ID23219A (enExample)
IL (1) IL129484A0 (enExample)
NO (1) NO991823L (enExample)
NZ (1) NZ335252A (enExample)
PE (1) PE20000472A1 (enExample)
PL (1) PL332564A1 (enExample)
SG (1) SG106035A1 (enExample)
SV (1) SV1999000052A (enExample)
TR (1) TR199900842A2 (enExample)
TW (1) TW555760B (enExample)
YU (1) YU19099A (enExample)
ZA (1) ZA992773B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301586A1 (en) * 1997-08-28 1999-03-04 William Louis Macias Method for treatment of non-rheumatoid arthritis
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
EP1303262A2 (en) * 2000-07-14 2003-04-23 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
AU2002239264A1 (en) * 2000-12-18 2002-07-01 Eli Lilly And Company Tetracyclic derivatives as spla2 inhibitors
US6933313B2 (en) 2001-03-28 2005-08-23 Eli Lilly And Company Substituted carbazoles as inhibitors of sPLA2
JP2005527466A (ja) * 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプトBインドール誘導体
JP2005527464A (ja) * 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプタBインドール誘導体
US6992100B2 (en) 2001-12-06 2006-01-31 Eli Lilly And Company sPLA2 inhibitors
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
BRPI0907122B8 (pt) 2008-01-11 2021-05-25 Albany Molecular Res Inc compostos de piridoindóis (1-azinona) substituídos, composição farmacêutica compreendendo os referidos compostos, e usos dos mesmos
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
JP5964945B2 (ja) * 2011-04-14 2016-08-03 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd 7−(ヘテロアリ−ル−アミノ)−6,7,8,9−テトラヒドロピリド[1,2−a]インド−ル酢酸誘導体及びプロスタグランジンD2受容体調節剤としてのそれらの使用
SG11201405328SA (en) 2012-03-16 2014-11-27 Vitae Pharmaceuticals Inc Liver x receptor modulators
SMT201700009T1 (it) 2012-03-16 2017-03-08 Vitae Pharmaceuticals Inc Modulatori del recettore x del fegato

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
BR9508298A (pt) * 1994-07-21 1998-11-03 Shionogi & Co Inibidores de indolizina de spla2
US6160175A (en) * 1995-12-13 2000-12-12 Eli Lilly And Company Naphthyl acetamides as sPLA2 inhibitors
KR20000049210A (ko) * 1996-10-30 2000-07-25 피터 지. 스트링거 치환된 트리시클릭류
CA2304482A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease

Similar Documents

Publication Publication Date Title
JPH11322713A5 (enExample)
JP2000026416A5 (enExample)
JP6672176B2 (ja) ボロン酸誘導体およびその治療的使用
JP3773257B2 (ja) 置換アザインドリリデン化合物及びその製造方法
CA2050331C (en) Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
JP2022506887A5 (enExample)
JPH06504779A (ja) 新規csaids
US20070232681A1 (en) Compounds Having Crth2 Antagonist Activity
JP2004537564A5 (enExample)
KR0150783B1 (ko) 포스핀산 유도체
NO175592C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive xantiner
KR950704228A (ko) 선택적 포스포디에스테르가수분해효소 iv형(pde_iv) 저해제로서의 카테콜 디에테르(catecol diethers as selective pde_iv inhibitors)
RU2008100164A (ru) Получение и применение соединений в качестве ингибиторов протеаз
JPH07503018A (ja) ピリジル置換イミダゾール
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
EP0072014A1 (en) Combination of 2-substituted penems with dipeptidase inhibitors
JP2003513961A (ja) シクロオキシゲナーゼ−2の阻害剤である5−アリール−1h−1,2,4−トリアゾール化合物とそれを含む医薬品組成物
AR049353A1 (es) Derivados de acido carboxilico de bencimidazolona como agonistas del receptor 5-ht4; composiciones farmaceuticas que los comprenden como principio activo e intermediarios utiles en su preparacion.
JP2022500499A5 (enExample)
JP2004512281A (ja) 抗炎症薬として有用なアミノ置換4環化合物および該化合物を含有する医薬組成物
CS226025B2 (en) Method of preparing cephalosporine derivatives
JP7728389B2 (ja) 3,6-二置換-2-ピリジンアルドキシム骨格
CS199713B2 (en) Process for preparing heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid
BG60346B2 (bg) Метод за получаване на z-2-ациламино-3-монозаместени пропеноати
TW201922755A (zh) 具有潛在反應性基團的頭孢烯化合物